Read More Pharma Industry News AstraZeneca to acquire Gracell Biotechnologies for $1.2bn to expand cell therapy capabilities AstraZeneca has announced a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL) for an upfront cash… byPallavi MadhirajuJanuary 2, 2024